Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) rose 2.3% during trading on Monday . The stock traded as high as $344.81 and last traded at $344.81. Approximately 11 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 905 shares. The stock had previously closed at $337.08.
Bio-Rad Laboratories Stock Down 3.3 %
The firm has a market cap of $9.12 billion, a price-to-earnings ratio of -11.92 and a beta of 0.72. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.14 and a quick ratio of 4.52. The firm’s fifty day moving average is $336.39 and its two-hundred day moving average is $317.98.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Articles
- Five stocks we like better than Bio-Rad Laboratories
- Where Do I Find 52-Week Highs and Lows?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
